- 1、本文档共23页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
糖尿病ACS患者抗血小板治疗PPT
Altered platelet functions in diabetes Diabetic thrombocytopathy refers to differences in platelet function between diabetic and nondiabetic individuals. Both diabetic and prediabetic conditions are associated with platelet and coagulation derangements. Increased platelet aggregability and adhesiveness in diabetes is due to a series of alterations in platelet functions. Because of the importance of platelet aggregation in thrombus formation, treatment strategies have focused on using antiplatelet agents to prevent recurrent events. Summary The objective was to describe the indices of platelet aggregation and activation in a large cohort of diabetic patients with coronary artery disease (CAD). Recently, a number of observations have indicated that patients with diabetes mellitus (DM) exhibit persistent platelet activation,and low response after antiplatelet therapy, although no randomized data exist.We sought to define the baseline platelet biomarkers,and the patterns of response to aspirin and clopidogrel therapy in DM versus non-diabetic patients. Secondary post-hoc analyses were made of platelet activity biomarkers in the dataset which consisted of patients with documented CAD (n=822), including those with DM (n=257). Patients with DM exhibited higher baseline platelet activity by adenosine diphosphate (ADP)- (p=0.0002), and collagen-induced (p=0.03) aggregometry; Ultegra- (p=0.0001), and PFA-100 (p=0.02) analyzers; and expression of platelet/en-dothelial cell adhesion molecule-1 (PECAM-1) (p=0.01), glycoprotein (GP) IIb/IIIa antigen (p=0.001), and activity (p=0.02), vitronectin receptor (p=0.03), P selectin (p=0.02), and intact epitope of PAR-1 thrombin receptor (p=0.02). Antiplatelet response after clopidogrel in diabetics was impaired when compared with non-diabetics. In conclusion, diabetic patients exhibit high pretreatment platelet activity, and do not respond well to the available antiplatelet regimens when compared with similar patients without DM.The
您可能关注的文档
- 第3章第一讲牛顿第一定律牛顿第三定律PPT.ppt
- 第十届世界肺癌会议(英文)PPT.ppt
- 策划书格式及范文PPT.ppt
- 第二次中国临床血脂控制状况多中心协作研究 武阳丰PPT.ppt
- 简历制作及面试技巧方法PPT.ppt
- 第七章、汽轮机调节系统PPT.ppt
- 简单手诊与实际操作PPT.ppt
- 简约ppt模板PPT.ppt
- 等离子质谱法PPT.ppt
- 简约大气实用PPT模板PPT.ppt
- FAIR 数据共享指导原则详解 _ 【官网】探码科技.pdf
- 非结构化数据管理与 AI Ready 数据准备白皮书预览版 _ Baklib.pdf
- 广东省惠阳市马安中学2023-2024学年中考数学五模试卷含解析.doc
- 广东省广州四中学2023-2024学年中考三模数学试题含解析.doc
- 广东省东莞市虎门汇英校2024年中考联考数学试题含解析.doc
- 广东省佛山市顺德区市级名校2023-2024学年中考数学适应性模拟试题含解析.doc
- 广东省高州市九校联考2024年毕业升学考试模拟卷数学卷含解析.doc
- 广东省东莞市五校2024届中考数学仿真试卷含解析.doc
- 广东省惠州光正实验2023-2024学年中考数学适应性模拟试题含解析.doc
- 广东省东莞市中学堂星晨校2024届中考联考数学试卷含解析.doc
文档评论(0)